Lexicon Pharmaceuticals
LXRX
#6808
Rank
โ‚น62.27 B
Marketcap
โ‚น146.99
Share price
-6.63%
Change (1 day)
159.53%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น18.02. In 2024 the company made an earnings per share (EPS) of -โ‚น60.69 an increase over its 2023 EPS that were of -โ‚น75.86.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-72.98%
2024-โ‚น60.69-20%
2023-โ‚น75.8631.15%
2022-โ‚น57.85-0%
2021-โ‚น57.8510.91%
2020-โ‚น52.16-145.08%
2019โ‚น115.69-206.09%
2018-โ‚น109.05-5.74%
2017-โ‚น115.69-10.95%
2016-โ‚น129.922640%
2015-โ‚น4.74-96.34%
2014-โ‚น129.40-2.53%
2013-โ‚น132.76-9.09%
2012-โ‚น146.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,685-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น519.67-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,089-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น553.81 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น597.43-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น47.42 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.12 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น172.59-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,274 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA